New China Life to invest RMB15bn in Fund III

New China Life Insurance Company Ltd. (HKEX: 1336) announced a proposed subscription of units in Fund III, committing up to RMB15 billion. The Board approved the capital contribution on June 12, 2025. Fund III, tentatively named Guofeng Xinghua Honghu Zhiyuan No. 1 Private Securities Investment Fund III, focuses on equity private securities investments, targeting stable dividend returns through low-frequency trading and long-term holdings. The fund size is RMB22.5 billion, with New China Life and China Life each contributing RMB11.25 billion. This transaction, when aggregated with a previous subscription involving China Life and Guofeng Xinghua, constitutes a discloseable transaction under the Hong Kong Listing Rules, requiring announcement but not shareholders' approval. The company advises caution to shareholders and potential investors due to uncertainties surrounding the regulatory filing process and implementation of Fund III.